Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blend Labs, Inc. (NYSE: BLND) files reports with the U.S. Securities and Exchange Commission as a Delaware corporation in the software publishers industry. On this BLND SEC filings page, Stock Titan aggregates the company’s regulatory disclosures, including current reports on Form 8-K and other periodic filings, and applies AI-powered summaries to help explain their contents in plain language.
Blend’s 8-K filings illustrate the types of material events the company reports to regulators and investors. Recent examples include the announcement of quarterly financial results, where Blend discusses software platform and professional services revenue, GAAP and non-GAAP gross margins, operating income or loss, and key operating metrics. Other 8-K filings cover leadership and executive transitions, such as changes in the Head of Finance and Administration role and related transition agreements, as well as appointments like the Head of Revenue.
Investors can also use this page to locate references to non-GAAP financial measures and the adjustments Blend applies, including stock-based compensation, workforce reduction costs, facilities-related charges, compensation realignment, litigation contingencies, transaction-related costs, software amortization and impairment, executive transition costs, and other items. These details are important for understanding how the company presents measures such as non-GAAP operating income and operating margin alongside GAAP results.
Stock Titan’s interface is designed to make it easier to work through Blend’s SEC disclosures. Users can quickly access quarterly and annual reports when available, review 8-K filings about results of operations, and see filings related to corporate governance or compensation matters. AI-generated highlights help surface the main points of each filing, including financial performance, key agreements, and leadership changes, so readers can navigate Blend’s regulatory history more efficiently.
Blend Labs (BLND) reported an equity grant to an officer on a Form 4. The Head of Finance and Administration received 2,200,000 restricted stock units (RSUs) on October 27, 2025, each representing one share of Class A common stock.
Per the award terms, 25% vests on August 20, 2026, with the remainder vesting in equal quarterly installments over the following three years, contingent on continued service. Following the grant, 2,200,000 derivative securities were reported as directly owned.
Blend Labs (BLND): insider equity change reported. A director and officer (Head of Blend) reported a transaction on 10/29/2025. The filing shows 371,000 shares of Class A Common Stock were acquired at a price of $0 under transaction code J, with total Class A beneficial ownership at 6,428,300 shares directly after the transaction.
The related note states that upon conversion of shares of Class B Common Stock, an equal number of Class A shares were pledged as collateral to secure certain personal indebtedness. Following the event, the reporting person also held 2,756,385 shares of Class B Common Stock, which are convertible into Class A on a one-for-one basis and have no expiration date.
Blend Labs (BLND) disclosed an insider transaction by its Head of Legal and People. On 10/20/2025, the reporting person sold 4,000 Class A shares at $3.50 per share under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the sale, the insider beneficially owned 380,631 shares, held directly.
Blend Labs (BLND) reported an insider transaction by its Head of Revenue. On 10/15/2025, the reporting person sold 25,000 shares of Class A common stock at a $3.3403 weighted average price, with individual trades ranging from $3.33 to $3.385. The sales were made under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the transaction, the insider beneficially owns 687,909 shares, held directly.
Blend Labs (BLND) received a Form 144 notice indicating an intended sale of 25,000 shares of common stock through Charles Schwab & Co., Inc. with an aggregate market value of $83,509, targeting an approximate sale date of October 15, 2025 on the NYSE. The form lists 255,696,747 shares outstanding.
The seller acquired these 25,000 shares on February 17, 2020 via “Exercise and Hold,” paid in cash. Recent activity disclosed three prior sales of 25,000 shares each on July 15, 2025 ($90,829), August 15, 2025 ($71,873), and September 15, 2025 ($109,069), by Brian Kneafsey.
Reporting person: Winnie Ling, Head of Legal and People and officer of Blend Labs, Inc. (BLND), reported a sale of common stock executed under a Rule 10b5-1 trading plan adopted on
The Form 4 shows a disposition of 4,000 shares of Class A common stock on
Blend Labs, Inc. (BLND) filed a Form 144 reporting a proposed sale of 4,000 common shares through Charles Schwab & Co., Inc. with an approximate sale date of 10/02/2025 on the NYSE. The shares were acquired on 02/20/2025 as the lapse of restricted stock under the company’s equity compensation plan and were paid by equity compensation.
The filing also lists multiple recent open-market sales by (and an address for) Winnie Ling across July–September 2025, each showing trade dates, share amounts, and gross proceeds. The Form 144 includes the seller’s representation that they are not aware of undisclosed material adverse information about the issuer.
Winnie Ling, Head of Legal and People at Blend Labs, Inc. (BLND), reported a sale of 6,500 shares of Class A common stock on 09/18/2025. The shares were sold under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, at a weighted average price of $4.2951 per share (sales ranged from $4.265 to $4.30). After the transaction, the reporting person beneficially owned 388,631 shares, held directly. The Form 4 was signed on 09/19/2025 and includes an offer to provide detailed per-price sale quantities to the Commission staff on request.
Form 144 notice for Blend Labs, Inc. (BLND)
This filing discloses a proposed sale of 6,500 common shares to be executed on 09/18/2025 through Charles Schwab & Co., with an aggregate market value listed as $27,918.00. The shares were acquired by the seller on 05/20/2024 via a restricted stock lapse as equity compensation from Blend Labs, Inc. The filing also reports prior sales by the same person, Winnie Ling, totaling 45,500 shares sold across seven transactions between 07/03/2025 and 09/05/2025, with aggregate gross proceeds of $169,091.00. The filer certifies no undisclosed material adverse information and follows Rule 144 disclosure requirements.
FAQ
What is the current stock price of Blend Labs (BLND)?
What is the market cap of Blend Labs (BLND)?
